甲状腺消融设备市场报告：趋势、预测和竞争分析（至 2031 年）

全球甲状腺消融设备市场前景光明，医院、门诊手术中心和专科癌症中心市场都存在机会。预计全球甲状腺消融设备市场从 2025 年到 2031 年的复合年增长率将达到 9.7%。该市场的主要驱动力是甲状腺癌发病率的上升以及对微创手术的倾向性日益增强。

• Lucintel 预测，射频消融术在预测期内仍将占据主要地位，因为它具有快速、安全、微创等优势，可以作为手术的替代方案。
• 根据最终用途，医院预计仍将是最大的部分。
• 从地区来看，由于甲状腺癌发病率上升以及该地区主要公司的存在，预计北美将在预测期内继续成为最大的地区。

甲状腺消融设备市场的策略性成长机会

甲状腺消融设备市场为希望利用日益增长的微创治疗需求的相关人员提供了众多策略性成长机会。随着人们对甲状腺疾病认识的提高和技术创新的进步，出现了几种扩展途径。利用这些机会可以帮助公司扩大市场份额、推动永续成长，同时改善患者的治疗效果。

• 扩展到新兴市场：新兴市场，尤其是亚洲和拉丁美洲，由于医疗保健投资的增加和人们对甲状腺健康的认识的提高，提供了巨大的成长潜力，为公司扩展业务提供了途径。
• 开发联合治疗：有机会开发将切除术与其他治疗方法（例如荷尔蒙疗法或标靶药物疗法）相结合的联合治疗，这可能会提高整体疗效和患者满意度。
• 专注于以患者为中心的解决方案：公司可以投资以患者为中心的解决方案，例如教育计划和支援服务，以提高患者的参与度和意识，最终推动对切除术的需求。
• 策略伙伴关係和合作：与医疗保健提供者、研究机构和技术公司建立策略伙伴关係可以促进创新、扩大新设备的分销、提高市场渗透率并共用专业知识。
• 投资研发：持续投资研发对于推进消融技术、满足不断变化的临床需求以及推出改善治疗结果的新设备至关重要。

甲状腺消融设备市场的策略性成长机会对于製造商和医疗保健提供者来说都是有利的。透过专注于扩张、创新和协作，相关人员不仅可以提高其市场地位，还可以为改善甲状腺管理中的患者照护做出重大贡献。

甲状腺消融设备市场驱动因素与挑战

在几个关键驱动因素的推动下，甲状腺消融设备市场正在经历显着成长。同时，影响市场扩张的挑战依然存在。了解这些动态对于相关人员有效驾驭不断发展的甲状腺治疗格局至关重要。确定成长催化剂和需要克服的障碍将有助于在这个竞争激烈的市场中做出策略决策。

推动甲状腺消融设备市场发展的因素有：

• 甲状腺疾病盛行率不断上升：甲状腺疾病（包括甲状腺结节和癌症）盛行率不断上升，推动了对有效治疗方案的需求，使甲状腺消融成为医疗保健提供者中越来越受欢迎的选择。
• 微创技术的进步：射频消融术和微波消融等微创消融技术的创新吸引了寻求微创手术的患者，促进了市场的成长和普及。
• 提高意识和教育：患者和医疗保健专业人员对甲状腺健康和可用治疗方案的认识不断提高，这推动了对甲状腺消融疗法的需求并提高了市场意识。
• 支持性法规环境：有利的法规环境和加速的新设备核准流程鼓励製造商创新并将先进产品推向市场，进一步刺激成长。
• 扩大门诊照护模式：向门诊照护模式的转变正在扩大切除术的可近性。患者喜欢较短的恢復时间和可以在医院外进行的侵入性较小的治疗。

甲状腺消融设备市场面临的主要挑战是：

• 设备高成本：特别是在对成本敏感的医疗保健市场中，先进的甲状腺消融设备的高成本可能会成为采用的障碍，限制一些患者和医疗保健提供者的获取。
• 临床指引的差异：不同地区不同的临床指引和治疗通讯协定可能会造成医疗保健提供者的混乱，并阻碍甲状腺消融技术的广泛应用。
• 患者认知度低：儘管认知度不断提高，但许多患者仍然不知道甲状腺消融是一种治疗选择，这可能会减缓这种创新治疗方法在临床实践中的应用。

总之，甲状腺消融设备市场受到技术进步和患者意识增强等多种强劲驱动因素的支持。然而，高成本和不一致的指导方针等挑战可能会阻碍成长。对于希望在这个不断发展的市场中发挥最大影响力的相关人员来说，应对这些挑战并利用已确定的驱动因素至关重要。

目录

第一章执行摘要

2. 全球甲状腺消融设备市场：市场动态

• 简介、背景和分类
• 供应链
• 产业驱动力与挑战

第三章市场趋势与预测分析（2019-2031）

• 宏观经济趋势（2019-2024）及预测（2025-2031）
• 全球甲状腺消融设备市场趋势（2019-2024）及预测（2025-2031）
• 全球甲状腺消融设备市场（按类型）
  • 射频消融术
  • 微波消融
  • 其他的
• 全球甲状腺消融设备市场（按产品）
  • 热敏设备
  • 非热能设备
• 全球甲状腺消融设备市场（按应用）
  • 甲状腺癌
  • 甲状腺结节
  • 其他的
• 全球甲状腺消融设备市场（依最终用途）
  • 医院
  • 门诊手术中心
  • 癌症中心
  • 其他的

第四章区域市场趋势与预测分析（2019-2031）

• 全球甲状腺消融设备市场（按地区）
• 北美甲状腺消融设备市场
• 欧洲甲状腺消融设备市场
• 亚太甲状腺消融设备市场
• 世界其他地区甲状腺消融设备市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球甲状腺消融设备市场成长机会（按类型）
  • 全球甲状腺消融设备市场成长机会（按产品）
  • 全球甲状腺消融设备市场的成长机会（按应用）
  • 全球甲状腺消融设备市场成长机会（依最终用途）
  • 全球甲状腺消融设备市场各区域成长机会
• 全球甲状腺消融设备市场的新趋势
• 战略分析
  • 新产品开发
  • 全球甲状腺消融设备市场产能扩张
  • 全球甲状腺消融设备市场的企业合併
  • 认证和许可

第七章主要企业简介

• Boston Scientific Corporation
• BVM Medical System
• Integra Life Sciences
• Johnson & Johnson
• Medtronic
• MedWaves
• Olympus Corporation
• StarMed
• Terumo Europe
• Theraclion

The future of the global thyroid ablation device market looks promising, with opportunities in the hospital, ambulatory surgical center, and cancer specialty center markets. The global thyroid ablation device market is expected to grow with a CAGR of 9.7% from 2025 to 2031. The major drivers for this market are the increasing incidence of thyroid cancer and the rising inclination toward minimally invasive procedures.

• Lucintel forecasts that, within the type category, radiofrequency ablation will remain the larger segment over the forecast period due to its advantages, like being quick, safe, and less invasive substitutes for surgery.
• Within the end use category, the hospital will remain the largest segment.
• In terms of region, North America will remain the largest region over the forecast period due to the rising incidence of thyroid cancer and the existence of key players in the region.

Gain valuable insight for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Thyroid Ablation Device Market

The thyroid ablation device market is rapidly evolving, influenced by technological advancements, changing patient preferences, and growing awareness of thyroid-related health issues. As healthcare professionals seek more effective and minimally invasive treatment options, several emerging trends are shaping the future of this market. These trends reflect innovations in device design, treatment methodologies, and patient care strategies, promising improved outcomes for individuals with thyroid disorders.

• Increased Adoption of Radiofrequency Ablation: Radiofrequency ablation (RFA) is gaining traction due to its minimally invasive nature, allowing for targeted destruction of thyroid nodules while preserving surrounding tissue. This leads to quicker recovery times for patients.
• Advancements in Imaging Techniques: Enhanced imaging technologies, such as ultrasound and CT scans, are playing a crucial role in improving the precision of thyroid ablation procedures, enabling better visualization of nodules and real-time monitoring during treatments.
• Development of Novel Devices: Manufacturers are focusing on the development of innovative ablation devices that combine multiple modalities, such as laser and microwave technologies, to improve efficacy, reduce procedure times, and expand treatment indications.
• Growing Patient Awareness: Increased awareness of thyroid disorders and treatment options is driving patient demand for minimally invasive procedures, prompting healthcare providers to adopt ablation techniques as a preferred choice over traditional surgery.
• Regulatory Support for New Technologies: Regulatory bodies are increasingly supportive of novel thyroid ablation devices, expediting approval processes and encouraging research and development. This is likely to spur market growth and innovation in the coming years.

The thyroid ablation device market is witnessing dynamic changes driven by these emerging trends. As technology continues to advance and patient needs evolve, the focus on minimally invasive and effective treatment options will likely dominate the market landscape, ultimately improving patient outcomes and satisfaction.

Recent Developments in the Thyroid Ablation Device Market

The thyroid ablation device market has seen remarkable developments in recent years, driven by technological innovation and an increasing focus on minimally invasive treatment options. These advancements aim to enhance patient outcomes, improve procedural efficiency, and expand the range of treatable conditions. As healthcare providers adopt these innovations, they are reshaping the landscape of thyroid management, providing patients with safer and more effective treatment alternatives.

• Launch of Advanced Ablation Systems: Recent launches of advanced ablation systems featuring improved radiofrequency and microwave technologies are enhancing precision in targeting thyroid nodules, leading to better outcomes and reduced complications.
• Integration of Artificial Intelligence: The integration of artificial intelligence in imaging and procedural planning is revolutionizing thyroid ablation, allowing for more accurate diagnoses and optimized treatment strategies, which significantly improve procedural success rates.
• Growth of Outpatient Procedures: There is a notable shift toward outpatient thyroid ablation procedures, driven by advancements in technology that enable faster recovery and reduced hospital stays, aligning with patient preferences for less invasive treatments.
• Expansion of Clinical Indications: New clinical studies are supporting the use of thyroid ablation for a broader range of indications, including larger nodules and recurrent cases, thereby expanding the patient population eligible for these minimally invasive therapies.
• Regulatory Approvals for Novel Devices: Recent regulatory approvals for innovative thyroid ablation devices are encouraging manufacturers to invest in research and development, fostering a competitive environment that enhances the overall quality and effectiveness of available treatments.

The recent developments in the thyroid ablation device market signal a transformative period for thyroid care. With advancements in technology, procedural approaches, and regulatory support, the future of thyroid management looks promising, offering patients safer and more effective treatment options tailored to their specific needs.

Strategic Growth Opportunities for Thyroid Ablation Device Market

The thyroid ablation device market presents numerous strategic growth opportunities for stakeholders seeking to capitalize on increasing demand for minimally invasive treatments. As awareness of thyroid disorders rises and technological innovations emerge, there are several avenues for expansion. By leveraging these opportunities, companies can enhance their market presence and drive sustainable growth while improving patient care outcomes.

• Expansion into Emerging Markets: Emerging markets, particularly in Asia and Latin America, offer significant growth potential due to rising healthcare investments and increasing awareness of thyroid health, providing an avenue for companies to expand their reach.
• Development of Combination Therapies: There is an opportunity to develop combination therapies that integrate thyroid ablation with other treatment modalities, such as hormonal therapy or targeted drug treatments, which could enhance overall efficacy and patient satisfaction.
• Focus on Patient-Centric Solutions: Companies can invest in patient-centric solutions, such as educational programs and support services, to increase patient engagement and awareness, ultimately driving demand for thyroid ablation procedures.
• Strategic Partnerships and Collaborations: Forming strategic partnerships with healthcare providers, research institutions, and technology firms can facilitate innovation and broaden the distribution of new devices, enhancing market penetration and fostering shared expertise.
• Investment in Research and Development: Continued investment in research and development is crucial for advancing ablation technologies and techniques, enabling the introduction of novel devices that meet evolving clinical needs and improve treatment outcomes.

The strategic growth opportunities within the thyroid ablation device market are promising for manufacturers and healthcare providers alike. By focusing on expansion, innovation, and collaboration, stakeholders can not only enhance their market positions but also significantly contribute to improved patient care in thyroid management.

Thyroid Ablation Device Market Driver and Challenges

The thyroid ablation device market is experiencing significant growth, propelled by several key drivers. At the same time, challenges remain that could impact market expansion. Understanding these dynamics is crucial for stakeholders aiming to navigate the evolving landscape of thyroid care effectively. Identifying both the catalysts for growth and the hurdles to overcome will help inform strategic decisions in this competitive market.

The factors responsible for driving the thyroid ablation device market include:

• Increasing Prevalence of Thyroid Disorders: The rising incidence of thyroid disorders, including nodules and cancer, is driving demand for effective treatment options, making thyroid ablation an increasingly popular choice among healthcare providers.
• Advancements in Minimally Invasive Techniques: Innovations in minimally invasive ablation technologies, such as radiofrequency and microwave ablation, are attracting patients seeking less invasive procedures, contributing to the market's growth and adoption.
• Growing Awareness and Education: Increased awareness of thyroid health and available treatment options among patients and healthcare professionals is fostering greater demand for thyroid ablation procedures, enhancing market visibility.
• Supportive Regulatory Environment: A favorable regulatory environment, with expedited approval processes for new devices, encourages manufacturers to innovate and bring advanced products to market, further driving growth.
• Expanding Outpatient Treatment Models: The shift toward outpatient care models is facilitating greater access to thyroid ablation procedures, as patients prefer shorter recovery times and less invasive options that can be performed outside of hospital settings.

Challenges in the thyroid ablation device market are:

• High Cost of Devices: The high cost associated with advanced thyroid ablation devices can be a barrier to adoption, particularly in cost-sensitive healthcare markets, limiting access for some patients and providers.
• Variability in Clinical Guidelines: Variability in clinical guidelines and treatment protocols across different regions can create confusion among healthcare providers, potentially hindering the widespread adoption of thyroid ablation techniques.
• Limited Awareness Among Patients: Despite growing awareness, many patients remain uninformed about thyroid ablation as a treatment option, which can slow down the uptake of these innovative therapies in clinical practice.

In conclusion, the thyroid ablation device market is buoyed by several strong drivers, including technological advancements and increasing patient awareness. However, challenges such as high costs and variability in guidelines may impede growth. Addressing these challenges while leveraging the identified drivers will be essential for stakeholders aiming to maximize their impact in this evolving market.

List of Thyroid Ablation Device Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, thyroid ablation device companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thyroid ablation device companies profiled in this report include-

• Boston Scientific Corporation
• BVM Medical System
• Integra Life Sciences
• Johnson & Johnson
• Medtronic
• MedWaves
• Olympus Corporation
• StarMed
• Terumo Europe
• Theraclion

Thyroid Ablation Device by Segment

The study includes a forecast for the global thyroid ablation device market by type, product, application, end use, and region.

Thyroid Ablation Device Market by Type [Analysis by Value from 2019 to 2031]:

• Radiofrequency Ablation
• Microwave Ablation
• Others

Thyroid Ablation Device Market by Product [Analysis by Value from 2019 to 2031]:

• Thermal Based Devices
• Non-Thermal Based Devices

Thyroid Ablation Device Market by Application [Analysis by Value from 2019 to 2031]:

• Thyroid Cancer
• Thyroid Nodules
• Others

Thyroid Ablation Device Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Ambulatory Surgical Centers
• Cancer Specialty Centers
• Others

Thyroid Ablation Device Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Thyroid Ablation Device Market

The thyroid ablation device market has seen significant advancements recently, driven by technological innovations, the increasing prevalence of thyroid disorders, and growing awareness of minimally invasive treatment options. These developments are shaping the landscape of healthcare across various countries, including the United States, China, Germany, India, and Japan. Each of these markets is experiencing unique trends that reflect their healthcare needs and economic conditions, fostering a competitive environment for device manufacturers and healthcare providers.

• United States: The U.S. market is witnessing rapid growth due to advancements in ultrasound-guided radiofrequency ablation technology, leading to increased adoption of these procedures among endocrinologists and surgeons.
• China: The thyroid ablation device market in China is expanding quickly, propelled by rising healthcare investments and a growing patient population seeking effective treatments for thyroid nodules and cancer.
• Germany: The German market is characterized by a strong emphasis on research and development, with local manufacturers innovating new technologies to improve efficacy and patient outcomes in thyroid ablation procedures.
• India: The thyroid ablation market in India is evolving as awareness of non-surgical treatment options grows, supported by the increasing incidence of thyroid disorders and the entry of international players into the healthcare sector.
• Japan: Japan is experiencing a surge in thyroid ablation procedures, driven by advancements in imaging technologies and a shift towards minimally invasive treatments, leading to improved patient satisfaction and outcomes.

Features of the Global Thyroid Ablation Device Market

Market Size Estimates: Thyroid ablation device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Thyroid ablation device market size by various segments, such as by type, product, application, end use, and region in terms of value ($B).

Regional Analysis: Thyroid ablation device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, products, applications, end uses, and regions for the thyroid ablation device market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the thyroid ablation device market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the thyroid ablation device market by type (radiofrequency ablation, microwave ablation, and others), product (thermal based devices and non-thermal based devices), application (thyroid cancer, thyroid nodules, and others), end use (hospitals, ambulatory surgical centers, cancer specialty centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market, and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years, and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Thyroid Ablation Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Thyroid Ablation Device Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Thyroid Ablation Device Market by Type
  • 3.3.1: Radiofrequency Ablation
  • 3.3.2: Microwave Ablation
  • 3.3.3: Others
• 3.4: Global Thyroid Ablation Device Market by Product
  • 3.4.1: Thermal Based Devices
  • 3.4.2: Non-Thermal Based Devices
• 3.5: Global Thyroid Ablation Device Market by Application
  • 3.5.1: Thyroid Cancer
  • 3.5.2: Thyroid Nodules
  • 3.5.3: Others
• 3.6: Global Thyroid Ablation Device Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Ambulatory Surgical Centers
  • 3.6.3: Cancer Specialty Centers
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Thyroid Ablation Device Market by Region
• 4.2: North American Thyroid Ablation Device Market
  • 4.2.1: North American Market by Type: Radiofrequency Ablation, Microwave Ablation, and Others
  • 4.2.2: North American Market by End Use: Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, and Others
• 4.3: European Thyroid Ablation Device Market
  • 4.3.1: European Market by Type: Radiofrequency Ablation, Microwave Ablation, and Others
  • 4.3.2: European Market by End Use: Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, and Others
• 4.4: APAC Thyroid Ablation Device Market
  • 4.4.1: APAC Market by Type: Radiofrequency Ablation, Microwave Ablation, and Others
  • 4.4.2: APAC Market by End Use: Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, and Others
• 4.5: ROW Thyroid Ablation Device Market
  • 4.5.1: ROW Market by Type: Radiofrequency Ablation, Microwave Ablation, and Others
  • 4.5.2: ROW Market by End Use: Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Thyroid Ablation Device Market by Type
  • 6.1.2: Growth Opportunities for the Global Thyroid Ablation Device Market by Product
  • 6.1.3: Growth Opportunities for the Global Thyroid Ablation Device Market by Application
  • 6.1.4: Growth Opportunities for the Global Thyroid Ablation Device Market by End Use
  • 6.1.5: Growth Opportunities for the Global Thyroid Ablation Device Market by Region
• 6.2: Emerging Trends in the Global Thyroid Ablation Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Thyroid Ablation Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Thyroid Ablation Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Boston Scientific Corporation
• 7.2: BVM Medical System
• 7.3: Integra Life Sciences
• 7.4: Johnson & Johnson
• 7.5: Medtronic
• 7.6: MedWaves
• 7.7: Olympus Corporation
• 7.8: StarMed
• 7.9: Terumo Europe
• 7.10: Theraclion